Funded Tech Companies
Dracen Pharmaceuticals
Dracen Pharmaceuticals, based in New York, received equity investments from Deerfield Capital.
Company Overview
Company Name
Dracen Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
780 3rd Ave. 45th Floor
New York, NY 10017
USA
New York, NY 10017
USA
Phone
Website
Email Address
Company Background Information
Overview
Dracen is a privately-funded biotech company developing drugs in the area of immuno-metabolism. Targeting immuno-metabolism promises to have broad acting effects on modulating immune responses in multiple disease settings.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/26/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Estok
Chief Medical Officer
Margaret Dugan
Chief Scientific Officer
Robert Wild
VP - Bus. Development
Mohamed Ragab
VP - Finance
Dennis Bilski
VP - Operations
Francois Lafleur
Company Investors
- Deerfield Capital (Jonathan Leff)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs